SEC Form 4 · accession 0001437749-18-016026
BIOLIFE SOLUTIONS INC · BLFS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Raymond W Cohen
Director
Period of report
Aug 21, 2018
Accepted (ET)
Aug 22, 2018 · 8:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000834365
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 21, 2018 | S | 10,000 | $23.68 | D | 33,031 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $23.59 to $23.92, inclusive. The reporting person undertakes to provide to BioLife Soultions, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Comission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.